Publication | Open Access
EGFR/ErbB2-Targeting Lapatinib Therapy for Aggressive Prolactinomas
64
Citations
18
References
2020
Year
An oral TKI such as lapatinib may be an effective option for a difficult-to-treat patient with an aggressive prolactinoma.
| Year | Citations | |
|---|---|---|
Page 1
Page 1